Julia Schüler

4.4k total citations · 1 hit paper
78 papers, 3.1k citations indexed

About

Julia Schüler is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Julia Schüler has authored 78 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 35 papers in Oncology and 13 papers in Immunology. Recurrent topics in Julia Schüler's work include Cancer Cells and Metastasis (14 papers), Cancer Genomics and Diagnostics (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Julia Schüler is often cited by papers focused on Cancer Cells and Metastasis (14 papers), Cancer Genomics and Diagnostics (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Julia Schüler collaborates with scholars based in Germany, United States and Austria. Julia Schüler's co-authors include Thomas Brabletz, Ulrich T. Hopt, Ulrich F. Wellner, Simone Brabletz, Ulrike Burk, Tobias Keck, Marc P. Stemmler, Jennifer P. Morton, Owen J. Sansom and Otto Schmalhofer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Julia Schüler

74 papers receiving 3.0k citations

Hit Papers

The EMT-activator ZEB1 promotes tumorigenicity by repress... 2009 2026 2014 2020 2009 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
    2009 1.4k citations Ulrich F. Wellner, Jörg Schubert et al. Nature Cell Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Schüler Germany 20 1.8k 1.4k 1.1k 301 296 78 3.1k
Zhenhe Suo Norway 32 1.8k 1.0× 1.3k 0.9× 872 0.8× 187 0.6× 447 1.5× 107 3.1k
Kyoko Hida Japan 34 2.5k 1.3× 956 0.7× 1.3k 1.2× 460 1.5× 318 1.1× 65 3.5k
Zhen Yang China 26 1.6k 0.9× 1.5k 1.1× 983 0.9× 143 0.5× 299 1.0× 77 3.2k
Enza Lonardo Italy 23 1.4k 0.7× 1.5k 1.1× 666 0.6× 188 0.6× 212 0.7× 37 2.6k
Xiaofeng Zheng United States 22 1.7k 0.9× 1.6k 1.1× 917 0.9× 125 0.4× 300 1.0× 52 2.9k
Tiziana Triulzi Italy 30 1.7k 0.9× 1.4k 1.0× 1.2k 1.1× 264 0.9× 345 1.2× 61 3.3k
Go J. Yoshida Japan 21 1.5k 0.8× 931 0.6× 949 0.9× 193 0.6× 313 1.1× 25 2.5k
Neethan A. Lobo United States 11 2.1k 1.1× 1.3k 0.9× 1.2k 1.1× 146 0.5× 211 0.7× 14 3.1k
Adriana Eramo Italy 32 2.5k 1.4× 1.9k 1.3× 1.1k 1.0× 226 0.8× 460 1.6× 49 4.1k
Ievgenia Pastushenko Belgium 10 1.6k 0.9× 1.2k 0.8× 973 0.9× 123 0.4× 349 1.2× 16 2.7k

Countries citing papers authored by Julia Schüler

Since Specialization
Citations

This map shows the geographic impact of Julia Schüler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Schüler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Schüler more than expected).

Fields of papers citing papers by Julia Schüler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Schüler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Schüler. The network helps show where Julia Schüler may publish in the future.

Co-authorship network of co-authors of Julia Schüler

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Schüler. A scholar is included among the top collaborators of Julia Schüler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Schüler. Julia Schüler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hoffmann, Johannes, Julia Schüler, Carsten Sticht, et al.. (2025). Steatohepatitis-induced vascular niche alterations promote melanoma metastasis. Cancer & Metabolism. 13(1). 5–5.
2.
Schüler, Julia, et al.. (2025). Efficient spin-wave excitation by surface acoustic waves in ultralow-damping yttrium iron garnet–zinc oxide heterostructures. Physical Review Applied. 24(1). 1 indexed citations
3.
4.
Schüler, Julia, Theresa H. Wirtz, Eray Yagmur, et al.. (2023). Secreted Frizzled Related Protein 5 (SFRP5) Serum Levels Are Decreased in Critical Illness and Sepsis and Are Associated with Short-Term Mortality. Biomedicines. 11(2). 313–313. 5 indexed citations
5.
Eßmann, Frank, Heike Horn, Julia Schüler, et al.. (2023). Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins. Frontiers in Oncology. 13. 1190988–1190988. 3 indexed citations
6.
7.
Vassal, Gilles, Peter J. Houghton, Stefan M. Pfister, et al.. (2021). International Consensus on Minimum Preclinical Testing Requirements for the Development of Innovative Therapies For Children and Adolescents with Cancer. Molecular Cancer Therapeutics. 20(8). 1462–1468. 16 indexed citations
8.
Müller, Stefan J., Dagmar Wider, Andreas Thomsen, et al.. (2017). Epigenetic Modifications of the Bone Marrow (BM) Niche in Multiple Myeloma (MM) - a Three-Dimensional (3D) in Vitro Approach. Blood. 130. 1793–1793. 1 indexed citations
9.
Kramer, Nina, Christine Unger, Harini Nivarthi, et al.. (2017). Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression. Oncogene. 36(39). 5460–5472. 105 indexed citations
10.
Unger, Christine, Nina Kramer, Daniela Unterleuthner, et al.. (2017). Stromal-derived IGF2 promotes colon cancer progression via paracrine and autocrine mechanisms. Oncogene. 36(38). 5341–5355. 61 indexed citations
11.
Greve, Gabriele, Insa Schiffmann, Dietmar Pfeifer, et al.. (2015). The pan-HDAC inhibitor panobinostat acts as a sensitizer for erlotinib activity in EGFR-mutated and -wildtype non-small cell lung cancer cells. BMC Cancer. 15(1). 947–947. 59 indexed citations
12.
Köhler, Christian, Rogério F. Lourenço, Jörg Bernhardt, et al.. (2015). A comprehensive genomic, transcriptomic and proteomic analysis of a hyperosmotic stress sensitive α-proteobacterium. BMC Microbiology. 15(1). 71–71. 16 indexed citations
13.
Brabletz, Simone, Bogdan‐Tiberius Preca, Manuel Ruh, et al.. (2015). ZEB 1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat. EMBO Molecular Medicine. 7(6). 831–847. 188 indexed citations
14.
Schneider, Meike, Nina Korzeniewski, Julia Schüler, et al.. (2014). The tyrosine kinase inhibitor nilotinib has antineoplastic activity in prostate cancer cells but up-regulates the ERK survival signal—Implications for targeted therapies. Urologic Oncology Seminars and Original Investigations. 33(2). 72.e1–72.e7. 10 indexed citations
15.
Schneider, Meike, Julia Schüler, Nina Korzeniewski, et al.. (2014). Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 32(6). 877–884. 9 indexed citations
16.
Deuschle, Ulrich, Julia Schüler, Andreas Schulz, et al.. (2012). FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model. PLoS ONE. 7(10). e43044–e43044. 72 indexed citations
17.
Wehr, Claudia, Fabian Müller, Julia Schüler, et al.. (2011). Anti‐tumor activity of a B‐cell receptor‐targeted peptide in a novel disseminated lymphoma xenograft model. International Journal of Cancer. 131(2). E10–20. 3 indexed citations
18.
Wellner, Ulrich F., Jörg Schubert, Ulrike Burk, et al.. (2009). The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nature Cell Biology. 11(12). 1487–1495. 1380 indexed citations breakdown →
19.
Fiebig, Heinz H., et al.. (2007). Determination of a 35 gene signature predictive for the effectiveness of Bevacizumab. Molecular Cancer Therapeutics. 6. 1 indexed citations
20.
Jordan, Andreas, Robert Scholz, Julia Schüler, Peter Wust, & R. Félix. (1997). Arrhenius analysis of the thermal response of human colonic adenocarcinoma cellsin vitrousing the multi-target, single-hit and the linear-quadratic model. International Journal of Hyperthermia. 13(1). 83–88. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenhe Suo Breakdown of academic impact, for papers by Kyoko Hida Breakdown of academic impact, for papers by Zhen Yang Breakdown of academic impact, for papers by Enza Lonardo Breakdown of academic impact, for papers by Xiaofeng Zheng Breakdown of academic impact, for papers by Tiziana Triulzi Breakdown of academic impact, for papers by Go J. Yoshida Breakdown of academic impact, for papers by Neethan A. Lobo Breakdown of academic impact, for papers by Adriana Eramo Breakdown of academic impact, for papers by Ievgenia Pastushenko
Rankless by CCL
2026